Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 118525-40-9
2. 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one
3. Ufe666uely
4. 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-4h-chromen-4-one
5. Sgn162
6. Sgn-162
7. Dtxsid00152154
8. 4h-1-benzopyran-4-one, 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-
9. 4h-1-benzopyran-4-one, 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-
10. Refchem:147599
11. Dtxcid4074645
12. Mfcd22422519
13. 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4h-1-benzopyran-4-one
14. Chembl498485
15. Unii-ufe666uely
16. Icartin
17. Icaritin (standard)
18. Icaritin(anhydroicaritin)?
19. Icaritin [who-dd]
20. Mls006010055
21. Bidd:er0021
22. Orb1304239
23. Schembl4223542
24. Icaritin, >=98% (hplc)
25. Schembl29360642
26. Hy-n0678r
27. Chebi:201674
28. Tuuxbsasaqjecy-uhfffaoysa-n
29. Hy-n0678
30. Bdbm50272527
31. S9080
32. Akos015896858
33. Ccg-268265
34. Cs-3679
35. Db12672
36. Ebc-460069
37. Fi24531
38. Ncgc00345813-01
39. Ncgc00345813-04
40. Ac-33950
41. As-55987
42. Da-74392
43. Smr004701218
44. I0974
45. Ns00014982
46. F557937
47. Brd-k24476327-001-01-3
48. Q27291061
49. 4'-methoxy-3,5,7trihydroxy-8-3,3-dimethylallylflavone
50. 3-hydroxy-7-o-beta-glucose-8-prenyl-4''-methoxy Chrysin
51. 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-4h-chromen-4-one
| Molecular Weight | 368.4 g/mol |
|---|---|
| Molecular Formula | C21H20O6 |
| XLogP3 | 4.8 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 96.2 |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 612 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
28
PharmaCompass offers a list of Icaritin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Icaritin manufacturer or Icaritin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Icaritin manufacturer or Icaritin supplier.
A Icaritin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Icaritin, including repackagers and relabelers. The FDA regulates Icaritin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Icaritin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Icaritin supplier is an individual or a company that provides Icaritin active pharmaceutical ingredient (API) or Icaritin finished formulations upon request. The Icaritin suppliers may include Icaritin API manufacturers, exporters, distributors and traders.
Icaritin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Icaritin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Icaritin GMP manufacturer or Icaritin GMP API supplier for your needs.
A Icaritin CoA (Certificate of Analysis) is a formal document that attests to Icaritin's compliance with Icaritin specifications and serves as a tool for batch-level quality control.
Icaritin CoA mostly includes findings from lab analyses of a specific batch. For each Icaritin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Icaritin may be tested according to a variety of international standards, such as European Pharmacopoeia (Icaritin EP), Icaritin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Icaritin USP).
